We are live on
!
Find out more
CM
Crestline Management Portfolio holdings
AUM
$46.3M
1-Year Est. Return
48.82%
This Fund
S&P 500
This Quarter
Est. Return
-10.85%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$1.06B
AUM Growth
-$96.4M
(-8.3%)
Cap. Flow
+$61.7M
Cap. Flow
% of AUM
5.81%
Top 10 Holdings %
Top 10 Hldgs %
52.73%
Holding
288
New
112
Increased
38
Reduced
29
Closed
52
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Willis Towers Watson
WTW
|
+$16.6M |
| 2 |
Bank of America
BAC
|
+$9.77M |
| 3 |
Goodyear
GT
|
+$9.11M |
| 4 |
FITB
Fifth Third Bancorp
FITB
|
+$9.08M |
| 5 |
Intercontinental Exchange
ICE
|
+$8.98M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Petrobras Class A
PBR.A
|
+$25M |
| 2 |
Denali Therapeutics
DNLI
|
+$24.3M |
| 3 |
Travelers Companies
TRV
|
+$8.53M |
| 4 |
PNC Financial Services
PNC
|
+$7.63M |
| 5 |
Morgan Stanley
MS
|
+$6.88M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 51.62% |
| 2 | Financials | 19.66% |
| 3 | Technology | 5.66% |
| 4 | Industrials | 4.81% |
| 5 | Materials | 4.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Denali Therapeutics
DNLI
$3.65B
| $389M | 36.56% |
7,705,039
-430,442
| -5% | -$24.3M |
|
2
Sana Biotechnology
SANA
$871M
| $72.3M | 6.8% |
3,210,937
| – | – |
|
|
3
Willis Towers Watson
WTW
$31.7B
| $17.3M | 1.63% |
+74,353
| New | +$16.6M |
|
4
Hartford Financial Services
HIG
$38.9B
| $15.8M | 1.49% |
225,511
+110,428
| +96% | +$7.3M |
|
5
American International
AIG
$41.7B
| $12M | 1.13% |
218,775
+63,775
| +41% | +$3.29M |
|
|
6
Bank of America
BAC
$435B
| $12M | 1.13% |
282,521
+242,521
| +606% | +$9.77M |
|
7
Ameriprise Financial
AMP
$48.3B
| $12M | 1.13% |
45,382
+159
| +0.4% | +$41.6K |
|
|
FITB
8
Fifth Third Bancorp
FITB
$51.2B
| $10.1M | 0.95% |
+236,945
| New | +$9.08M |
|
|
9
Goodyear
GT
$2B
| $9.93M | 0.93% |
+561,115
| New | +$9.11M |
|
|
CMA
10
DELISTED
Comerica
CMA
| $8.94M | 0.84% |
111,006
+71,006
| +178% | +$5.11M |
|
11
Zurn Elkay Water Solutions
ZWS
$8.38B
| $8.75M | 0.82% |
282,676
-7,964
| -3% | -$223K |
|
|
12
Intercontinental Exchange
ICE
$85.6B
| $8.68M | 0.82% |
+75,626
| New | +$8.98M |
|
13
American Express
AXP
$227B
| $8.45M | 0.79% |
50,414
+5,414
| +12% | +$905K |
|
14
Alphabet (Google) Class A
GOOGL
$4.36T
| $8.27M | 0.78% |
61,840
+21,300
| +53% | +$2.9M |
|
15
MetLife
MET
$61.9B
| $7.79M | 0.73% |
126,114
-32,749
| -21% | -$1.97M |
|
16
Teck Resources
TECK
$29.6B
| $7.76M | 0.73% |
311,363
+203,363
| +188% | +$4.66M |
|
|
ARNC
17
DELISTED
Arconic Corporation
ARNC
| $7.49M | 0.7% |
237,505
+82,831
| +54% | +$2.83M |
|
18
W.R. Berkley
WRB
$26.9B
| $7.43M | 0.7% |
228,454
+66,515
| +41% | +$2.19M |
|
19
Arthur J. Gallagher & Co
AJG
$64.1B
| $7.12M | 0.67% |
+47,884
| New | +$6.85M |
|
20
Citizens Financial Group
CFG
$30.3B
| $7.11M | 0.67% |
+151,363
| New | +$6.65M |
|
|
HOLX
21
DELISTED
Hologic
HOLX
| $7.11M | 0.67% |
+96,338
| New | +$7.22M |
|
22
Amazon
AMZN
$2.92T
| $6.97M | 0.66% |
42,460
+13,340
| +46% | +$2.3M |
|
|
MBAC
23
DELISTED
M3-Brigade Acquisition II Corp.
MBAC
| $6.94M | 0.65% |
+700,000
| New | +$6.85M |
|
24
Commercial Metals
CMC
$7.6B
| $6.7M | 0.63% |
+220,071
| New | +$7.01M |
|
25
FirstEnergy
FE
$28B
| $6.46M | 0.61% |
181,258
+78,658
| +77% | +$2.99M |
|
Similar funds
MCMC
RRC
PCM
NPCM
FCM
EGI
IPHI
SM
Crestline Management's Q3 2021 Portfolio in Review
As of Q3 2021, Crestline Management held 288 positions worth $1.06B, down 8.3% from $1.16B the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Crestline Management deployed $61.7M of net new capital in Q3 2021, opening 112 new positions and adding to 38 existing holdings. Its largest new stake was Willis Towers Watson: 74,353 shares worth $17.3M.
By sector, the portfolio is most concentrated in Healthcare at 52% of assets, down from 62% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Denali Therapeutics, an estimated $24.3M trimmed.
- Crestline Management's largest Q3 2021 buy was Willis Towers Watson: 74,353 shares worth $17.3M.
- Crestline Management added most to Bank of America in Q3 2021, an estimated $9.77M increase.
- Crestline Management's biggest Q3 2021 reduction was Denali Therapeutics, cutting an estimated $24.3M.
- Crestline Management fully exited Petrobras Class A in Q3 2021, selling an estimated $25M.
- Crestline Management's ten largest holdings make up 53% of its $1.06B portfolio in Q3 2021.
- Crestline Management opened 112 new positions and closed 52 in Q3 2021.
- Crestline Management's portfolio value fell 8.3% quarter-over-quarter to $1.06B.
Based on Crestline Management's 13F filing for Q3 2021, filed 12 Nov 2021.